Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Dupilumab SAR231893

Dupilumab SAR231893

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Dupilumab SAR231893

15 trials tracked of Dupilumab SAR231893: 15 in phase 3 or 4 and 10 with published results. The most-cited published study has 235 citations.

15Trials tracked
15Phase 3 & 4
0Recruiting
10With published results
Phase distribution
Phase 4 4 Phase 3 11
  1. Phase 3 Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation Completed · 235 cited
  2. Phase 3 Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME) Completed · 218 cited
  3. Phase 3 Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) Completed · 22 cited
  4. Phase 3 A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps Completed · 20 cited
  5. Phase 3 Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps Completed · 20 cited
  6. Phase 3 Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation Completed · 19 cited
Show 9 more trials
  1. Phase 3 Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up) Completed · 17 cited
  2. Phase 3 Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) Completed · 10 cited
  3. Phase 4 Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis Completed
  4. Phase 4 Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52) Completed
  5. Phase 4 Dupilumab Skin Barrier Function Study in Atopic Dermatitis Completed
  6. Phase 4 Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis Completed
  7. Phase 3 Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS) Completed
  8. Phase 3 Dupilumab in CRSsNP Completed
  9. Phase 3 Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI) Completed

Showing the 15 most-cited and recently-updated of 15 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.